Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Filaggrin-2 is a large, S100 fused-type structural protein found in the granular keratinocytes of human skin, encoded by the *FLG2* gene[2]. Functionally, it is similar to filaggrin, mediating epidermal differentiation, cornification, and formation of the stratum corneum, which maintains the skin barrier. Filaggrin-2 undergoes proteolytic processing to provide free amino acids that contribute to natural moisturizing factors, regulate stratum corneum pH, and afford photoprotection. Mutations or reduced expression of *FLG2*, as seen in some atopic dermatitis patients, result in skin barrier impairment, increased sensitivity to UV radiation, abnormal cornification (parakeratosis), altered proteolytic processing of related proteins, and reduced quantities of protective amino acids[2]. Filaggrin-2's deficiency is linked to chronic skin diseases such as atopic dermatitis and persistent barrier dysfunction. It is one of several epidermal S100 fused-type proteins involved in skin health and disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Filaggrin-2 (FLG2).